BY JOSEPH GUSTAITIS | JUNE 10, 2022 A while back we reported on how a medication (brand name Trulicity) created to treat one illness (diabetes) had been shown to be effective in treating another (heart disease). Now, according to research just published in the medical journal JAMA Ophthalmology, we now have another instance of a medication meant for...
by Bob Yirka, Medical Xpress Credit: Jenriquecf/Wikimedia Commons, CC BY-SA 4.0 A team of researchers at the University of Pennsylvania has found that administration of a drug currently used to reduce cholesterol levels in the bloodstream can reduce the risk of developing proliferative diabetic retinopathy (PDR) from non-proliferative diabetic retinopathy (NPDR). In their paper published in JAMA Ophthalmology, the...
